Edwards Lifesciences Corporation (BMV:EW)

Edwards Lifesciences Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	889,789	909,821	781,824	899,785	1,658,132	1,131,402
Market Cap Growth	-8.96%	16.37%	-13.11%	-45.73%	46.56%	23.28%
Enterprise Value	828,862	833,119	763,173	879,267	1,635,365	1,119,359
Last Close Price	1466.69	1543.21	1286.75	1425.52	2511.00	1795.37
PE Ratio	10.41	10.46	32.98	30.31	53.81	69.05
PS Ratio	7.88	8.03	9.23	10.33	15.46	12.96
PB Ratio	4.27	4.34	6.88	7.94	13.86	12.43
P/TBV Ratio	6.07	6.20	9.06	10.59	18.62	18.52
P/FCF Ratio	-	150.61	71.94	47.38	57.51	87.84
P/OCF Ratio	-	80.51	51.63	37.87	46.70	53.93
EV/Sales Ratio	7.74	7.35	9.01	10.10	15.25	12.83
EV/EBITDA Ratio	24.93	24.44	27.66	26.81	46.34	39.52
EV/EBIT Ratio	27.89	27.00	30.35	29.24	50.28	42.74
EV/FCF Ratio	64.05	137.92	70.23	46.30	56.73	86.91
Debt / Equity Ratio	0.07	0.07	0.10	0.12	0.12	0.15
Debt / EBITDA Ratio	0.41	0.42	0.41	0.40	0.39	0.48
Debt / FCF Ratio	1.11	2.42	1.07	0.71	0.49	1.07
Asset Turnover	0.49	0.49	0.57	0.53	0.67	0.64
Inventory Turnover	0.98	1.12	1.10	0.90	1.63	1.50
Quick Ratio	3.33	3.13	2.06	1.87	2.07	2.24
Current Ratio	4.45	4.18	3.38	3.03	3.08	3.46
Return on Equity (ROE)	16.51%	16.64%	19.48%	22.74%	28.88%	18.88%
Return on Assets (ROA)	8.42%	8.26%	10.53%	11.47%	12.60%	11.99%
Return on Capital (ROIC)	10.20%	10.19%	13.37%	14.80%	16.81%	16.30%
Return on Capital Employed (ROCE)	13.20%	12.80%	18.20%	21.20%	21.20%	20.70%
Earnings Yield	9.60%	9.56%	3.03%	3.30%	1.86%	1.45%
FCF Yield	1.45%	0.66%	1.39%	2.11%	1.74%	1.14%
Buyback Yield / Dilution	2.05%	1.66%	2.37%	1.11%	0.11%	0.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.